Corti S, Locatelli F, Papadimitriou D, Strazzer S, Bonato S, Comi G P
Dino Ferrari Center, Neurological Department, University of Milan, IRCCS, Policlinico Hospital, Via Francesco Sforza 35, 20122 Milan, Italy.
Histol Histopathol. 2005 Jul;20(3):977-86. doi: 10.14670/HH-20.977.
Cell-based therapy may represent a new strategy to treat a vast array of clinical disorders including neurodegenerative diseases. Recent observations indicate that adult somatic stem cells have the capacity to contribute to the regeneration of different tissues, suggesting that differentiative restrictions are not completely irreversible and can be reprogrammed. Cell fusion might account for some changed phenotype of adult cells but it seems to be biologically irrelevant for its extreme rarity. Other experimental evidences are compatible with the hypothesis of wide multipotency of well-defined stem cell populations, but also with transdifferentiation and/or dedifferentiation. Further studies on nuclear reprogramming mechanisms are necessary to fulfil the promise for developing autologous cellular therapies.
基于细胞的疗法可能代表一种治疗包括神经退行性疾病在内的一系列临床疾病的新策略。最近的观察表明,成体体细胞干细胞有能力促进不同组织的再生,这表明分化限制并非完全不可逆,并且可以重新编程。细胞融合可能解释了成体细胞某些改变的表型,但由于其极为罕见,在生物学上似乎并不相关。其他实验证据与明确的干细胞群体具有广泛多能性的假说相符,但也与转分化和/或去分化相符。有必要对核重编程机制进行进一步研究,以实现开发自体细胞疗法的前景。